Small chemical modifications can have significant effects on ligand efficacy and receptor activity, but the underlying structural mechanisms can be difficult to predict from static crystal structures alone. Here we show how a simple phenyl-to-pyridyl substitution between two common covalent orthosteric ligands targeting peroxisome proliferator-activated receptor gamma (PPARγ) converts a transcriptionally neutral antagonist (GW9662) into an inverse agonist (T0070907). X-ray crystallography, molecular dynamics simulations, and mutagenesis coupled to activity assays reveal a water-mediated hydrogen bond network linking the T0070907 pyridyl group to Arg288 that is essential for inverse agonism. NMR spectroscopy reveals that PPARγ exchanges between two long-lived conformations when bound to T0070907 but not GW9662, including a conformation that prepopulates a corepressor-bound state, priming PPARγ for high affinity corepressor binding. Our findings demonstrate that ligand engagement of Arg288 may provide new routes for developing PPARγ inverse agonist.
Introduction

1
The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARγ) bound PPARγ from the GW9662-bound PPARγ crystal structure solvated without 126 crystallized waters (model). In the simulations, the pyridyl group of T0070907 was 127 hydrogen bonded to a water molecule for a significant fraction of the simulation (65-128 95%), as was the water-bridged R288-T0070907 pyridyl (5-46%). In contrast, a direct 129 interaction between R288 and the pyridyl group of T0070907 not mediated by water was 130 lowly populated (<2%). A direct (4-64%) and water-bridged (3-61%) R288-E295 131 interaction was also confirmed. The extensive pyridyl-based water-mediated hydrogen 132 bond network is not possible to the hydrophobic phenyl group of GW9662, revealing a 133 unique chemical feature in T0070907 that could confer inverse agonism.
134
The pyridyl-water network is essential for inverse agonism 135 To test the functional role of the pyridyl-water hydrogen bond network observed 136 in our T0070907-bound crystal structure, we generated variants of PPARγ by mutating 137 residues that we predicted would maintain or break the pyridyl-water network. We 138 hypothesized that mutation of R288 to a different positively charged residue (R288K) 139 would maintain the pyridyl-water network, whereas mutation to a hydrophobic residue 140 (R288A or R288L) would break the pyridyl-water network. If the hydrogen bond 141 network is important for inverse agonism, we hypothesized that breaking this network 142 via hydrophobic R288 mutations would afford a similar functional efficacy profile for 143 both T0070907 and GW9662. We also generated a E295A mutation to test the importance 144 of the bipartite hydrogen bond between R288 and E295. These mutations did not affect bond is not a major contributor to stabilizing the repressive activity, though both 156 GW9662 and T0070907 showed lower activity compared to wild-type PPARγ.
157
We next tested the effect of the mutants on coregulator recruitment by 158 determining binding affinities for the TRAP220 ( Figure 3B ) and NCoR ( Figure 3C ) 159 peptides for wild-type PPARγ LBD and the mutant variants with or without 160 pretreatment with GW9662 or T0070907. Consistent with the cell-based transcription 161 assay, the R288K and E295A mutants maintained the inverse agonist coregulator 162 binding profile of T0070907 and rank ordering. In contrast, the R288A and R288L 163 mutants showed similar affinity for TRAP220 and NCoR when covalently bound to 164 T0070907 or GW9662. This indicates the pyridyl-water network directs the inverse 165 agonism profile of T0070907, the lack of which results in a neutral antagonist profile.
166
To more robustly compare how the wild-type and mutant PPARγ variants 167 performed in the above assays, we performed a version of the "web of efficacy" analysis 168 used in the G-protein coupled receptor (GPCR) field to study ligand signaling bias 23, 24 .
169
We plotted the multivariate data on a radar chart with axes corresponding to each of the 170 assays whereby conditions with the most efficacious (i.e., that are biased towards) 171 inverse agonism properties populate the outer ring of the radar chart, and less favorable 172 or efficacious conditions populate the center (Figure 3F ). The analysis clearly shows that 173 T0070907 selects more efficacious inverse agonism functions only for wild-type PPARγ 174 and the R288K mutant variant (Figure 3G ). This dramatic result reveals that R288-175 mediated pyridyl-water network directs inverse agonism conferred by T0070907.
176
T0070907-bound PPARγ exchanges between two long-lived conformations
177
Despite the different inverse agonist and neutral antagonist profiles of T0070907 178 and GW9662, the pyridyl-water network is the primary structural difference observed in 179 the crystal structures. In principle, there should be structural changes in the AF-2 180 coregulator interaction surface to account for the different pharmacological profiles.
181
Notably, however, the conformation of the AF-2 surface, which includes helix 12, is 182 influenced by crystal contacts ( Figure S2) . Furthermore, structural superposition of
183
PPARγ crystal structures bound to pharmacologically distinct ligands shows no major 184 structural changes that explain their different activities 25 . However, NMR studies have
185
shown that the orthosteric pocket and helix 12 are dynamic on the microsecond-to-186 millisecond (µs-ms) time scale in the ligand-free/apo-form, which results in very broad 187 or unobserved NMR peaks for residues in helix 12 and within the orthosteric pocket and 188 surrounding regions 6, 13 . Binding of a noncovalent full agonist stabilizes the helix 12/AF-189 2 surface resulting in the appearance of NMR peaks that were missing in the apo-form,
190
whereas noncovalent partial agonists, neutral antagonists, and inverse agonists do not 191 stabilize helix 12 6, 13, 25 .
192
We used NMR spectroscopy to assess the impact of T0070907 and GW9662 on (kex) between conformations on the order of milliseconds-to-seconds (ms-s) 27 
238
T0070907 populates a mutual conformation with GW9662 and a unique conformation
239
G399 is an ideal NMR observable probe that is sensitive to the conformation of 240 the AF-2 surface: it is structurally proximal and linked to the AF-2 surface through 241 water-mediated hydrogen bonds to N312 and D311 on helix 5, but does not directly 242 interact with a bound coregulator peptide ( Figure 5A) . Strikingly, for G399 and the other 243 residues that showed peak doubling in the ZZ exchange analysis, we found that the and Figure S4B ). This indicates that one of the long-lived T0070907-bound 247 conformations is structurally similar to GW9662-bound PPARγ, which below we refer to 248 as the mutual conformation, and the other conformation is uniquely populated only 249 when bound to T0070907.
250
We also assessed the conformational state of helix 12 directly using 19 
268
The unique T0070907 conformation prepopulates a corepressor-bound conformation 269 We wondered whether the unique and mutual long-lived T0070907-bound timescale dynamics relative to GW9662-bound PPARγ. Furthermore, using 19 promoting bone formation rather than decreasing bone mass 5, 6 , which occurs with 394 agonists used clinically such as the TZDs. Furthermore, repression of PPARγ activity 395 affects fat mobilization and may be a means to therapeutically treat obesity and extend 396 lifespan 7 , and T0070907 has demonstrated efficacy in cancer models [9] [10] [11] . Thus, our 397 findings should inspire future work to develop and characterize inverse agonists to 398 probe the repressive functions of PPARγ.
399
Methods
400
Materials and reagents
401
Human PPARγ LBD (residues 203-477 in isoform 1 numbering, which is 402 commonly used in published structural studies and thus throughout this manuscript; or 403 residues 231-505 in isoform 2 numbering) or mutant proteins were expressed in
404
Escherichia coli BL21(DE3) cells as TEV-cleavable hexahistidine-tagged fusion protein 405 using a pET46 plasmid as previously described 13, 26 . The final storage buffer for samples 
462
Molecular dynamics simulations
463
A crystal structure of GW9662-bound PPARγ (PDB code 3B0R) along with our 464 crystal structure T0070907 bound to PPARγ (PDB code 6C1I) were used to build initial 465 structures in all simulations in this study. Two models were generated using 3B0R 466 crystal structure. In the first model, chain A of 3B0R was used and GW9662 was 
481
Parmchk2 was used to create two force modification files from the prepin file, one that 482 used AMBER ff14SB 45 parameter database values and another that used general Amber hydrogen mass repartitioning. Analysis of trajectories was performed using cpptraj 49 .
503
Hydrogen bond analysis was performed using dist = 3.5 Å and angle = 100° 50 .
504
CD Spectroscopy
505
Protein samples pre-incubated with or without a 2X molar excess of covalent respectively. NMR chemical shift assignments previously described for ligand-bound 523 PPARγ 6,13,26 were assigned to the spectra for well resolved residues with consistent 524 NMR peak positions the presence of different ligands using the minimum chemical shift 525 perturbation procedure williamson 53 . ZZ exchange data were fit to an exchange model 526 for slow two-state interconversion 27,54 using a protocol described by, and a MATLAB 527 script provided by, Gustafson, et al. 55 . Orange and purple shaded areas note the affinity regions for an ideal inverse agonist (i.e., for weaker TRAP220 affinity, orange circles in the orange square; for higher NCoR affinity, purple circles in purple squares). (E) Superposition of crystal structures of the PPARγ LBD bound to GW9662 (PDB code 3B0R; ligand in green, cartoon in blue) and SR1664 (PDB code 4R2U; ligand in yellow). The location of the simple substitution between GW9662 (methine) vs. T0070907 (nitrogen) is marked with a black circle, and the SR2595 and SR10221 tert-butyl extension within the helix 12 subpocket towards F282 (blue) from the SR1664 parent compound is marked with a yellow circle. (A) Overall structure of T0070907-bound PPARγ (PDB code 6C1I; grey) and overlay with GW9662-bound crystal structure (PDB code 3B0R; blue). (B) A water-mediated hydrogen bond network in the T0070907-bound crystal structure (chain B is shown) links the pyridyl group in T0070907 to the R288 side chain, which forms a bipartite hydrogen bond with the E295 side chain. (C) The GW9662-bound crystal structure (chain B is shown) lacks the R288-ligand hydrogen bond network but contains the R288-E295 hydrogen bond. (D) Pyridyl-water network hydrogen bonds populated during molecular dynamics simulations for T0070907-and GW9662-bound structures starting from crystallized (xtal) and modeled (model) conformations. (F) , respectively, to better illustrate the peak transitions: 1, disappearance of the state A or B peak; 2, the redistribution of their intensities to the other state; and 3, the slight shifting of the other state towards, increased population of, the peptide-bound state. 
